Cargando…

Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study

BACKGROUND: Adult patients with hematologic malignancies are less likely to receive palliative care and more likely to accept intensive anti-cancer treatments until end-of-life than those with solid tumors, but limited data are available regarding the quality of end-of-life care (EOLC) for children...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yotani, Nobuyuki, Shinjo, Daisuke, Kato, Motohiro, Matsumoto, Kimikazu, Fushimi, Kiyohide, Kizawa, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186077/ https://www.ncbi.nlm.nih.gov/pubmed/34098925 http://dx.doi.org/10.1186/s12904-021-00776-5

Ejemplares similares

Advance care planning for adolescent patients with life-threatening neurological conditions: a survey of Japanese paediatric neurologists
por: Yotani, Nobuyuki, et al.
Publicado: (2017)

Preoperative factors affecting cost and length of stay for isolated off-pump coronary artery bypass grafting: hierarchical linear model analysis
por: Shinjo, Daisuke, et al.
Publicado: (2015)

Predictors associated with unplanned hospital readmission of medical and surgical intensive care unit survivors within 30 days of discharge
por: Ohnuma, Tetsu, et al.
Publicado: (2018)

Hospital mortality of patients aged 80 and older after surgical repair for type A acute aortic dissection in Japan
por: Ohnuma, Tetsu, et al.
Publicado: (2016)

Pandemic‐resilient target setting in colorectal cancer screening for vulnerable older population
por: Shibata, Toshiaki, et al.
Publicado: (2022)

Prescribed daily-dose–based metrics of oral antibiotic use for hospitalized children in Japan
por: Mimura, Wataru, et al.
Publicado: (2023)

End-of-life care in children with hematologic malignancies
por: Hoell, Jessica I., et al.
Publicado: (2017)

Pre-transplant Rehabilitation to Decrease the Post-transplant Length of Stay for Hematological Malignancy Patients Undergoing Allo-HSCT
por: Matsugaki, Ryutaro, et al.
Publicado: (2021)

Amino acids in hematologic malignancies: Current status and future perspective
por: Wang, Mengyao, et al.
Publicado: (2023)

Analysis of concordance with antiemetic guidelines in pediatric, adolescent, and young adult patients with cancer using a large‐scale administrative database
por: Bun, Seiko, et al.
Publicado: (2019)

Consultation-liaison psychiatry in Japan: a nationwide retrospective observational study
por: Shinjo, Daisuke, et al.
Publicado: (2021)

Development of a set of quality indicators in paediatric and perinatal care in Japan with a modified Delphi method
por: Shinjo, Daisuke, et al.
Publicado: (2023)

Intensity and duration of neutropenia relates to the development of oral mucositis but not odontogenic infection during chemotherapy for hematological malignancy
por: Kishimoto, Megumi, et al.
Publicado: (2017)

Current status of palliative care delivery and self-reported practice in ICUs in Japan: a nationwide cross-sectional survey of physician directors
por: Igarashi, Yuko, et al.
Publicado: (2022)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Incidence and risk of falls in patients treated for hematologic malignancies in the Intensive Hematology Unit
por: Lorca, Luz Alejandra, et al.
Publicado: (2019)

Intensive care unit outcomes in patients with hematological malignancy
por: Rawson, Jarrod Leigh, et al.
Publicado: (2020)

A systematic review of prognostic factors at the end of life for people with a hematological malignancy
por: Button, Elise, et al.
Publicado: (2017)

2566. Effect of CYP2C19 on Voriconazole Pharmacokinetics in Children with Malignancy or Inborn Errors in Immunity
por: Shoji, Kensuke, et al.
Publicado: (2023)

The Current Status of Microvascular Decompression for the Treatment of Trigeminal Neuralgia in Japan: An Analysis of 1619 Patients Using the Japanese Diagnosis Procedure Combination Database
por: MIZOBUCHI, Yoshifumi, et al.
Publicado: (2018)

Current Progress in CAR-T Cell Therapy for Hematological Malignancies
por: Han, Donglei, et al.
Publicado: (2021)

Liquid biopsy in hematological malignancies: current and future applications
por: Talotta, Donatella, et al.
Publicado: (2023)

An Anecdotal Outpatient Approach to Caring for Patients With End-Stage Hematologic Malignancies
por: Honor, Mark
Publicado: (2018)

Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies
por: Xie, Bailu, et al.
Publicado: (2022)

Predictors of intensive care unit admission in patients with hematologic malignancy
por: Vijenthira, Abi, et al.
Publicado: (2020)

Resource-rich Intensive Care Units vs. Standard Intensive Care Units on Patient Mortality: A Nationwide Inpatient Database Study
por: Ohbe, Hiroyuki, et al.
Publicado: (2021)

The Current Status of Microvascular Decompression for the Treatment of Hemifacial Spasm in Japan: An Analysis of 2907 Patients Using the Japanese Diagnosis Procedure Combination Database
por: MIZOBUCHI, Yoshifumi, et al.
Publicado: (2017)

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021)

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
por: Zhang, Xiaomin, et al.
Publicado: (2022)

Nutritional status of children and adolescents at diagnosis of hematological and solid malignancies
por: Lemos, Priscila dos Santos Maia, et al.
Publicado: (2014)

CAR-T cell therapy for hematological malignancies: History, status and promise
por: Wang, Chao, et al.
Publicado: (2023)

The prognostic factors for patients with hematological malignancies admitted to the intensive care unit
por: Cheng, Qian, et al.
Publicado: (2016)

Reply to: Resource-rich Intensive Care Units Improve Health―What Is Next?
por: Ohbe, Hiroyuki, et al.
Publicado: (2022)

Differential diagnosis of infectious diseases, drug-induced lung injury, and pulmonary infiltration due to underlying malignancy in patients with hematological malignancy using HRCT
por: Tanaka, Nobuyuki, et al.
Publicado: (2022)

The Association of Hematological Malignancy and End-of-Life Expenditure in Cancer Decedents: A Population-Based Study in an Asian Country
por: Hung, Yeh-Ting, et al.
Publicado: (2015)

Association between palliative care and end-of-Life care for patients with hematological malignancies: A population-based study
por: Chiang, Jui-Kun, et al.
Publicado: (2019)

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
por: Abedin, Sameem M, et al.
Publicado: (2016)

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies
por: Na, Il‐Kang, et al.
Publicado: (2019)

Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies
por: Orsini, Paola, et al.
Publicado: (2018)

Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
por: Liseth, Knut, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_98468f1a9lh69i6teh1mm2cq9i